newsfilter
← Latest News
Business Wire·

Humanigen Announces Abstracts Accepted for the British Thoracic Society Winter Meeting 2021

Abstract #S48 describes top-line results from the Humanigen Phase 3 LIVE-AIR study in hospitalized COVID-19 patients, which reveal a 54% relative improvement in the likelihood of survival without invasive mechanical ventilation ("SWOV") in lenzilumab-